Interleucina 1 alfa (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Interleucina 1 alfa" in Galician language version.

Last modified: 12:15:12, 4 July 2026 (UTC)

Ref.Un. Ref.Website

Global rank Galician rank

2523nih.gov

5^th place

2^nd place

2019doi.org

2^nd place

3^rd place

109archive.org

6^th place

4^th place

11nature.com

207^th place

72^nd place

archive.org (Global: 6^th place; Galician: 4^th place)

Bankers-Fulbright JL, Kalli KR, McKean DJ (1996). "Interleukin-1 signal transduction". Life Sciences 59 (2): 61–83. PMID 8699924. doi:10.1016/0024-3205(96)00135-X.
Gery I, Handschumacher RE (Mar 1974). "Potentiation of the T lymphocyte response to mitogens. III. Properties of the mediator(s) from adherent cells". Cellular Immunology 11 (1–3): 162–9. PMID 4549027. doi:10.1016/0008-8749(74)90016-1.
Hauser C, Saurat JH, Schmitt A, Jaunin F, Dayer JM (May 1986). "Interleukin 1 is present in normal human epidermis". Journal of Immunology 136 (9): 3317–23. PMID 3007615.
Feldmann M, Saklatvala J (2001). "Proinflammatory cytokines". En Durum SK, Oppenheim JJ, Feldmann M. Cytokine reference: a compendium of cytokines and other mediators of host defense. Boston: Academic Press. pp. 291–306. ISBN 978-0-12-252673-2.
Arend WP, Malyak M, Guthridge CJ, Gabay C (1998). "Interleukin-1 receptor antagonist: role in biology". Annual Review of Immunology 16: 27–55. PMID 9597123. doi:10.1146/annurev.immunol.16.1.27.
Neta R, Douches S, Oppenheim JJ (Apr 1986). "Interleukin 1 is a radioprotector". Journal of Immunology 136 (7): 2483–5. PMID 3512714.
Dorie MJ, Allison AC, Zaghloul MS, Kallman RF (May 1989). "Interleukin 1 protects against the lethal effects of irradiation of mice but has no effect on tumors in the same animals". Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 191 (1): 23–9. PMID 2654945. doi:10.3181/00379727-191-42884.
Constine LS, Harwell S, Keng P, Lee F, Rubin P, Siemann D (Mar 1991). "Interleukin 1 alpha stimulates hemopoiesis but not tumor cell proliferation and protects mice from lethal total body irradiation". International Journal of Radiation Oncology, Biology, Physics 20 (3): 447–56. PMID 1995530. doi:10.1016/0360-3016(91)90056-A.
Smith JW, Longo DL, Alvord WG, Janik JE, Sharfman WH, Gause BL, Curti BD, Creekmore SP, Holmlund JT, Fenton RG (Mar 1993). "The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin". The New England Journal of Medicine 328 (11): 756–61. PMID 8437596. doi:10.1056/NEJM199303183281103.

doi.org (Global: 2^nd place; Galician: 3^rd place)

dx.doi.org

Nicklin MJ, Weith A, Duff GW (Jan 1994). "A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes". Genomics 19 (2): 382–4. PMID 8188271. doi:10.1006/geno.1994.1076.
March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K (Aug 1985). "Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs". Nature 315 (6021): 641–7. PMID 2989698. doi:10.1038/315641a0.
Bankers-Fulbright JL, Kalli KR, McKean DJ (1996). "Interleukin-1 signal transduction". Life Sciences 59 (2): 61–83. PMID 8699924. doi:10.1016/0024-3205(96)00135-X.
Gery I, Gershon RK, Waksman BH (Jul 1972). "Potentiation of the T-lymphocyte response to mitogens. I. The responding cell". The Journal of Experimental Medicine 136 (1): 128–42. PMC 2139184. PMID 5033417. doi:10.1084/jem.136.1.128.
Gery I, Waksman BH (Jul 1972). "Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s)". The Journal of Experimental Medicine 136 (1): 143–55. PMC 2139186. PMID 5033418. doi:10.1084/jem.136.1.143.
Gery I, Handschumacher RE (Mar 1974). "Potentiation of the T lymphocyte response to mitogens. III. Properties of the mediator(s) from adherent cells". Cellular Immunology 11 (1–3): 162–9. PMID 4549027. doi:10.1016/0008-8749(74)90016-1.
Watanabe N, Kobayashi Y (Nov 1994). "Selective release of a processed form of interleukin 1 alpha". Cytokine 6 (6): 597–601. PMID 7893968. doi:10.1016/1043-4666(94)90046-9.
Gahring LC, Buckley A, Daynes RA (Oct 1985). "Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum". The Journal of Clinical Investigation 76 (4): 1585–91. PMC 424137. PMID 2997285. doi:10.1172/JCI112141.
Barland CO, Zettersten E, Brown BS, Ye J, Elias PM, Ghadially R (Feb 2004). "Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis" (PDF). The Journal of Investigative Dermatology 122 (2): 330–6. PMID 15009713. doi:10.1046/j.0022-202X.2004.22203.x.
Yin H, Morioka H, Towle CA, Vidal M, Watanabe T, Weissbach L (Aug 2001). "Evidence that HAX-1 is an interleukin-1 alpha N-terminal binding protein". Cytokine 15 (3): 122–37. PMID 11554782. doi:10.1006/cyto.2001.0891.
Hu B, Wang S, Zhang Y, Feghali CA, Dingman JR, Wright TM (Aug 2003). "A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression". Proceedings of the National Academy of Sciences of the United States of America 100 (17): 10008–13. PMC 187743. PMID 12913118. doi:10.1073/pnas.1737765100.
Arend WP, Malyak M, Guthridge CJ, Gabay C (1998). "Interleukin-1 receptor antagonist: role in biology". Annual Review of Immunology 16: 27–55. PMID 9597123. doi:10.1146/annurev.immunol.16.1.27.
Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993). "Interleukin-10". Annual Review of Immunology 11: 165–90. PMID 8386517. doi:10.1146/annurev.iy.11.040193.001121.
Dorie MJ, Allison AC, Zaghloul MS, Kallman RF (May 1989). "Interleukin 1 protects against the lethal effects of irradiation of mice but has no effect on tumors in the same animals". Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 191 (1): 23–9. PMID 2654945. doi:10.3181/00379727-191-42884.
Constine LS, Harwell S, Keng P, Lee F, Rubin P, Siemann D (Mar 1991). "Interleukin 1 alpha stimulates hemopoiesis but not tumor cell proliferation and protects mice from lethal total body irradiation". International Journal of Radiation Oncology, Biology, Physics 20 (3): 447–56. PMID 1995530. doi:10.1016/0360-3016(91)90056-A.
Smith JW, Longo DL, Alvord WG, Janik JE, Sharfman WH, Gause BL, Curti BD, Creekmore SP, Holmlund JT, Fenton RG (Mar 1993). "The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin". The New England Journal of Medicine 328 (11): 756–61. PMID 8437596. doi:10.1056/NEJM199303183281103.
Korneev, KV; Atretkhany, KN; Drutskaya, MS; Grivennikov, SI; Kuprash, DV; Nedospasov, SA (January 2017). "TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis.". Cytokine 89: 127–135. PMID 26854213. doi:10.1016/j.cyto.2016.01.021.
Reichert JM (2015). "Antibodies to watch in 2015". mAbs 7 (1): 1–8. PMC 4622967. PMID 25484055. doi:10.4161/19420862.2015.988944.
Valente Duarte de Sousa IC (Oct 2014). "Novel pharmacological approaches for the treatment of acne vulgaris". Expert Opinion on Investigational Drugs 23 (10): 1389–410. PMID 24890096. doi:10.1517/13543784.2014.923401.

nature.com (Global: 207^th place; Galician: 72^nd place)

Barland CO, Zettersten E, Brown BS, Ye J, Elias PM, Ghadially R (Feb 2004). "Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis" (PDF). The Journal of Investigative Dermatology 122 (2): 330–6. PMID 15009713. doi:10.1046/j.0022-202X.2004.22203.x.

nih.gov (Global: 5^th place; Galician: 2^nd place)

ncbi.nlm.nih.gov

Nicklin MJ, Weith A, Duff GW (Jan 1994). "A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes". Genomics 19 (2): 382–4. PMID 8188271. doi:10.1006/geno.1994.1076.
March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K (Aug 1985). "Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs". Nature 315 (6021): 641–7. PMID 2989698. doi:10.1038/315641a0.
Bankers-Fulbright JL, Kalli KR, McKean DJ (1996). "Interleukin-1 signal transduction". Life Sciences 59 (2): 61–83. PMID 8699924. doi:10.1016/0024-3205(96)00135-X.
Dinarello CA (Jun 1997). "Induction of interleukin-1 and interleukin-1 receptor antagonist". Seminars in Oncology 24 (3 Suppl 9): S9–81–S9–93. PMID 9208877.
Gery I, Gershon RK, Waksman BH (Jul 1972). "Potentiation of the T-lymphocyte response to mitogens. I. The responding cell". The Journal of Experimental Medicine 136 (1): 128–42. PMC 2139184. PMID 5033417. doi:10.1084/jem.136.1.128.
Gery I, Waksman BH (Jul 1972). "Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s)". The Journal of Experimental Medicine 136 (1): 143–55. PMC 2139186. PMID 5033418. doi:10.1084/jem.136.1.143.
Gery I, Handschumacher RE (Mar 1974). "Potentiation of the T lymphocyte response to mitogens. III. Properties of the mediator(s) from adherent cells". Cellular Immunology 11 (1–3): 162–9. PMID 4549027. doi:10.1016/0008-8749(74)90016-1.
Watanabe N, Kobayashi Y (Nov 1994). "Selective release of a processed form of interleukin 1 alpha". Cytokine 6 (6): 597–601. PMID 7893968. doi:10.1016/1043-4666(94)90046-9.
Hauser C, Saurat JH, Schmitt A, Jaunin F, Dayer JM (May 1986). "Interleukin 1 is present in normal human epidermis". Journal of Immunology 136 (9): 3317–23. PMID 3007615.
Gahring LC, Buckley A, Daynes RA (Oct 1985). "Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum". The Journal of Clinical Investigation 76 (4): 1585–91. PMC 424137. PMID 2997285. doi:10.1172/JCI112141.
Schmitt A, Hauser C, Jaunin F, Dayer JM, Saurat JH (1986). "Normal epidermis contains high amounts of natural tissue IL 1 biochemical analysis by HPLC identifies a MW approximately 17 Kd form with a P1 5.7 and a MW approximately 30 Kd form". Lymphokine Research 5 (2): 105–18. PMID 3486328.
Barland CO, Zettersten E, Brown BS, Ye J, Elias PM, Ghadially R (Feb 2004). "Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis" (PDF). The Journal of Investigative Dermatology 122 (2): 330–6. PMID 15009713. doi:10.1046/j.0022-202X.2004.22203.x.
Yin H, Morioka H, Towle CA, Vidal M, Watanabe T, Weissbach L (Aug 2001). "Evidence that HAX-1 is an interleukin-1 alpha N-terminal binding protein". Cytokine 15 (3): 122–37. PMID 11554782. doi:10.1006/cyto.2001.0891.
Hu B, Wang S, Zhang Y, Feghali CA, Dingman JR, Wright TM (Aug 2003). "A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression". Proceedings of the National Academy of Sciences of the United States of America 100 (17): 10008–13. PMC 187743. PMID 12913118. doi:10.1073/pnas.1737765100.
Arend WP, Malyak M, Guthridge CJ, Gabay C (1998). "Interleukin-1 receptor antagonist: role in biology". Annual Review of Immunology 16: 27–55. PMID 9597123. doi:10.1146/annurev.immunol.16.1.27.
Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993). "Interleukin-10". Annual Review of Immunology 11: 165–90. PMID 8386517. doi:10.1146/annurev.iy.11.040193.001121.
Neta R, Douches S, Oppenheim JJ (Apr 1986). "Interleukin 1 is a radioprotector". Journal of Immunology 136 (7): 2483–5. PMID 3512714.
Dorie MJ, Allison AC, Zaghloul MS, Kallman RF (May 1989). "Interleukin 1 protects against the lethal effects of irradiation of mice but has no effect on tumors in the same animals". Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 191 (1): 23–9. PMID 2654945. doi:10.3181/00379727-191-42884.
Constine LS, Harwell S, Keng P, Lee F, Rubin P, Siemann D (Mar 1991). "Interleukin 1 alpha stimulates hemopoiesis but not tumor cell proliferation and protects mice from lethal total body irradiation". International Journal of Radiation Oncology, Biology, Physics 20 (3): 447–56. PMID 1995530. doi:10.1016/0360-3016(91)90056-A.
Smith JW, Longo DL, Alvord WG, Janik JE, Sharfman WH, Gause BL, Curti BD, Creekmore SP, Holmlund JT, Fenton RG (Mar 1993). "The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin". The New England Journal of Medicine 328 (11): 756–61. PMID 8437596. doi:10.1056/NEJM199303183281103.
Korneev, KV; Atretkhany, KN; Drutskaya, MS; Grivennikov, SI; Kuprash, DV; Nedospasov, SA (January 2017). "TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis.". Cytokine 89: 127–135. PMID 26854213. doi:10.1016/j.cyto.2016.01.021.
Reichert JM (2015). "Antibodies to watch in 2015". mAbs 7 (1): 1–8. PMC 4622967. PMID 25484055. doi:10.4161/19420862.2015.988944.
Valente Duarte de Sousa IC (Oct 2014). "Novel pharmacological approaches for the treatment of acne vulgaris". Expert Opinion on Investigational Drugs 23 (10): 1389–410. PMID 24890096. doi:10.1517/13543784.2014.923401.

Interleucina 1 alfa (Galician Wikipedia)

archive.org (Global: 6th place; Galician: 4th place)

doi.org (Global: 2nd place; Galician: 3rd place)